Code-Free Clinician Self-Training on Public Data for Diabetic Retinopathy Referral
This quality improvement study evaluates clinician-driven, self-trained use of automated machine learning and public data sets in designing high-performing diabetic retinopathy classification models. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Advances in Artificial Intelligence Chatbot Technology in Ophthalmology —Reply
In Reply We sincerely thank Lin and colleagues for their comments on our article. Using a free trial of OphthoQuestions, a popular question bank for ophthalmology board certification preparation, we found that ChatGPT-3.5 correctly answered 58 of 125 questions in January 2023 (46%) and 73 of 125 questions in February 2023 (58%). Lin and colleagues make the argument that since this time, the accuracy of ChatGPT has increased. We completely agree and note the findings of our recent investigation published in JAMA Ophthalmology. Here, we found that ChatGPT-4 correctly answered 105 of 125 questions of the same question bank in...
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019 —Reply
In Reply We thank Drs Groth and Donahue for their insights on our recent publication. In their Letter to the Editor, they suggest that the rise in retinopathy of prematurity (ROP) incidence may not be as substantial as the article concluded. While this proposition is possible, we do not believe that their presented hypotheses provide the best explanation for our study ’s findings. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Bruton Tyrosine Kinase Inhibitor in 2 Patients With Vitreoretinal Lymphoma
This case report describes the use of tirabrutinib to treat 2 individuals with vitreoretinal lymphoma. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Advances in Artificial Intelligence Chatbot Technology in Ophthalmology
To the Editor We read with interest the timely article by Mihalache and colleagues. Using the free GPT-3.5 version of ChatGPT released in November 2022, the authors show that this artificial intelligence (AI) chatbot correctly answered half of OphthoQuestions ’ practice questions. In this letter, we highlight the higher performance of the more recent GPT-4 version of ChatGPT (released in April 2023) compared with GPT-3.5, ophthalmologists, and ophthalmologists-in-training on practice material for the written examination of the American Board of Ophthal mology (ABO). (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019
To the Editor The recent article by Bhatnagar et al described a relatively constant incidence of retinopathy of prematurity (ROP) from 2003 until about 2006, followed by a relatively linear rise until 2012, followed again by a relatively constant incidence (Figure 1). This increase in ROP over time is surprising given the relative stability in factors that correlate with ROP; furthermore, this type of incidence curve does not appear to be physiologic. As the authors mention, there were neither associated changes in survival nor alterations in management. We propose other factors may in part be responsible for these observa...
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Bilateral Endophthalmitis After Immediate Sequential Bilateral Cataract Surgery
This case series investigates factors associated with an outbreak of bilateral simultaneous postoperative endophthalmitis following cataract surgery performed the same day at a single clinic. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
JAMA Ophthalmology
Mission Statement: To be the indispensable source of ophthalmic knowledge by promptly publishing innovative, clinically relevant research through consistent and authoritative peer review and, thereby, to be the first choice of authors for their important manuscripts. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - November 1, 2023 Category: Opthalmology Source Type: research
Punctal Plug Granuloma After Blepharoplasty
This case report discusses a diagnosis of foreign body granuloma resulting from a punctal plug in a patient aged 66 years with chronic dry eye and a history of blepharoplasty. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 19, 2023 Category: Opthalmology Source Type: research
Lymphangiectasia Hemorrhagica Conjunctivae Regression After Bleomycin Sclerotherapy
This case report discusses treatment of lymphangiectasia hemorrhagica conjunctivae with bleomycin sclerotherapy in a patient aged 47 years with a history of recurrent subconjunctival hemorrhage. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 19, 2023 Category: Opthalmology Source Type: research
Uveal Exposure Following Globe Rupture Simulating Conjunctival Melanoma
This case report describes a diagnosis of uveal prolapse masquerading as a conjunctival melanoma after globe rupture in a woman aged 89 years. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 19, 2023 Category: Opthalmology Source Type: research
Progressive Retinal Medullated Nerve Fiber Layer in a Young Boy
This case report documents progression of myelinated retinal nerve fibers in a young boy from age 6 months to 2 years. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 19, 2023 Category: Opthalmology Source Type: research
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years
This randomized clinical trial investigates if low-dose atropine, 0.01% or 0.02%, slows the progression of myopia in children. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 1, 2023 Category: Opthalmology Source Type: research
Reducing the Risks of Nuclear War —The Role of Health Professionals
In January 2023, the Science and Security Board of the Bulletin of the Atomic Scientists moved the hands of the Doomsday Clock forward to 90 seconds before midnight, reflecting the growing risk of nuclear war. In August 2022, the UN Secretary-General Ant ónio Guterres warned that the world is now in “a time of nuclear danger not seen since the height of the Cold War.” The danger has been underlined by growing tensions between many nuclear armed states. As editors of health and medical journals worldwide, we call on health professionals to alert the public and our leaders to this major danger to public health and the e...
Source: JAMA Ophthalmology - October 1, 2023 Category: Opthalmology Source Type: research
JAMA Network Call for Papers on Health and the 2024 US Election
Nationally and globally, health will continue to be one of the most important policy issues for the 2024 US election. Information about these health issues is critical for decision-making and to answer pressing public and global health questions affecting the US and the world. US elections are not only domestic; they affect world politics, economies, security, welfare, and health. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - October 1, 2023 Category: Opthalmology Source Type: research
